The purpose of this review is to examine recent advances in the techniques and technologies of endoscopic resection of early gastric cancer (EGC). Endoscopic mucosal resection (EMR) of EGC, with negligible risk of lymph node metastasis, is a standard technique in Japan and is increasingly becoming accepted and regularly used in Western countries. EMR is a minimally invasive technique which is safe, convenient, and effi cacious; however, it is insuffi cient when treating larger lesions. The evidence suggests that diffi culties with the correct assessment of depth of tumor invasion lead to an increase in local recurrence with standard EMR when lesions are larger than 15 mm. A major factor contributing to this increase in local recurrence relates to lesions being excised piecemeal due to the technical limitations of standard EMR. A new development in endoscopic techniques is to dissect directly along the submucosal layer -a procedure called endoscopic submucosal dissection (ESD). This allows the en-bloc resection of larger lesions. ESD is not necessarily limited by lesion size and it is predicted to replace conventional surgery in dealing with certain stages of ECG. However, it still has a higher complication rate when compared to standard EMR, and it requires high levels of endoscopic skill and experience. Endoscopic techniques, indications, pathological assessment, and methods of endoscopic resection of EGC need to be established for carrying out appropriate treatment and for the collation of long-term outcome data.
Introduction
In the management of early gastric cancer (EGC) (see Fig. 1 ), a major role is played by therapeutic endoscopy. Its indications can be broadly divided into four categories: (1) excision or fulguration, (2) palliative recanalization of luminal obstruction, (3) hemorrhage control, and (4) others. Endoscopic excision of cancer, using a high-frequency electric current (HFEC), or fulguration, using laser irradiation, microwave coagulation, or local injection of anticancer agents has been used with the intention to cure. Re-canalization of luminal obstruction can be achieved using endoscopic laser irradiation, microwave coagulation, bougienage, or stent placement. Endoscopic injection of pure alcohol or hypertonic saline with diluted epinephrine, the application of heater probe, argon plasma, or microwave coagulation, and HFEC or laser irradiation have been used to arrest bleeding from cancer, with varying degrees of success.
The role of endoscopic surgery in the management of EGC will be the focus of this review.
Endoscopic treatment for EGC is currently standard practice in Japan; outside Japan, it is increasingly gaining acceptance worldwide [1, 2] . Endoscopic resection is comparable in many respects to conventional surgery, with the advantages of being less invasive and more economical. The extremely low incidence of lymph involvement in certain stages of EGC means that cure can be accomplished by such local treatment in selected cases. Endoscopic resection allows complete pathological staging of the cancer, which is critical, as this allows stratifi cation and refi nement of further treatment [3] . Patients who are identifi ed to have no risk or a low risk of developing lymph node metastasis, relative to the perioperative risks associated with surgery, are ideal candidates for endoscopic resection [4] . Other endoscopic techniques may also cure EGC by fulgurating it, but they do not provide any pathological specimen [5] . Without a specimen, tumor stage cannot be assessed. Thus, the patient's prognosis cannot be estimated and potential needs for additional therapy, which may be curative, cannot be assessed [6, 7] .
Recent advances, including the categorizing of endoscopic resection as standard endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) will be described.
Principle of endoscopic resection
EGC is defi ned as GC in which tumor invasion is confi ned to the mucosa or submucosa (T1 cancer), irrespective of lymph node status [8] , considering the adverse impact of lymph node metastasis on a patient's prognosis [9, 10] . Gastrectomy with lymph node dissection had been the gold standard treatment here in Japan for all patients with operable gastric cancer, including EGC [11] [12] [13] . This policy of radical surgery for all such cases carries signifi cant risks of morbidity and mortality and is associated with a long-term reduction in patients' quality of life [14, 15] .
Analyses of databases containing hundreds of thousands of pathology reports, patients' histories, and longterm survival data from the National Cancer Center Hospital and other units in Japan have demonstrated that the 5-year cancer-specifi c survival rates of EGC limited to the mucosa or the submucosa are 99% and 96%, respectively [16] . In patients with cancer limited to the mucosa, the incidence of lymph node metastasis is less than 3%. By comparison, this risk increases to around 20% when the cancer invades the submucosa [17] . With stratifi cation, subgroups of patients with EGC who have practically no risk of lymph node metastasis have been identifi ed [18] . Patients with EGC who meet these very specifi c endoscopic and pathological criteria are ideal candidates to have their cancer excised through the endoscope. Patients who have lesions suspected to contain EGC are also ideal candidates to undergo endoscopic resection.
The major advantage of endoscopic resection is its ability to provide pathological staging without precluding future surgical therapy [19, 20] . After endoscopic resection, pathological assessment of depth of cancer invasion, degree of differentiation of the cancer, and extent of lymphovascular invasion allows the risk of lymph node metastasis to be predicted, using published data of patients with similar fi ndings [21] . The risk of developing lymph node metastasis or distant metastasis is then weighed against the risk of surgery [22] . Such precise staging, unfortunately, cannot be achieved as accurately with any imaging technique currently available [23] . For example, while endoscopic ultrasound (EUS) is accurate for tumor depth staging, this is only possible in 80% to 90% of cases [24] . Hence, any treatment plan based on EUS recommendations potentially means that, in 10% to 20% of cases, patients may be subjected to unnecessary surgery [25] [26] [27] . The fi nal staging can only be done through formal histological analysis, which endoscopic excision can achieve [28, 29] .
Indications for endoscopic resection
Currently accepted indications for endoscopic resection of EGC include the resection of small intramucosal EGCs of intestinal histology type (Fig. 2) [30] . The rationale for this recommendation is based upon the knowledge that larger-size lesions or lesions with diffuse histology type are more likely to extend into the submucosal layer and thus have a higher risk of lymph node metastasis. In addition, resection of large lesion has not been technically feasible until the development of ESD techniques. Therefore, at present, the accepted indications for EMR are: (1) well-differentiated elevated cancers less than 2 cm in diameter and (2) small (Ϲ1 cm) depressed lesions without ulceration. Also, these lesions must be moderately or well-differentiated cancers confi ned to the mucosa and have no lymphatic or vascular involvement [31] . Clinical observations have noted, however, that the accepted indications for ER can be too strict and can lead to unnecessary surgery [32] . Therefore, extended criteria for ER have been proposed. The upper limit of the 95% confi dence interval (CI) calculated from these early studies, however, was too broad for clinical use because of their small sample size [33] [34] [35] [36] [37] . More recently, however, using a large database involving more than 5000 patients who underwent gastrectomy with meticulous R2 level lymph node dissection, Gotoda and colleagues [38] were able to defi ne further the risk of lymph node metastasis in additional groups of patients with EGC with increased certainty (Table 1) . These groups of patients were shown to have no or lower risks of lymph node metastasis than the risks of mortality from surgery. The results of this study have allowed the development of an expanded list of candidates suitable for endoscopic resection (Fig. 3 ) [39] .
Endoscopic resection for cure in EGC
Learning from the successful application of polypectomy used to remove early colon cancer [40] , endoscopic polypectomy to treat pedunculated or semipedunculated EGC was fi rst described in Japan in 1974. By 1984, an EMR technique called the "strip biopsy" (Fig. 4A ) was fi rst described as an extension of endoscopic snare polypectomy [41] . In this method, a double-channel endoscope is used. After submucosal injection of saline under the lesion, the lesion is lifted using a grasper, while a snare, inserted through the second working channel, is used to remove the lesion. In 1988, another technique, EMR with the local injection of hypertonic saline/diluted epinephrine solution was described [42] . In this technique, after the injection of hypertonic saline and diluted epinephrine, the periphery of the lesion is cut using a needle knife. The lesion is then removed using a snare. EMR allowed increased precision to be applied, thus permitting the entire lesion to be removed en bloc. However, the technique also requires considerable skills, and the use of the needle knife has higher risks for perforation. A method of EMR with a cap-fi tted panendoscope (EMR-C), developed in 1992 for the resection of early esophageal cancer, was directly applicable for the resection of EGC (Fig. 4B) [43] . The technique utilizes a clear plastic cap that is connected to the tip of a standard endoscope. Different sized caps are available according to the diameter of the endoscope and the size of the target lesions [44] (Fig. 5) . After the submucosal injection of the lesion, a specialized crescent-shaped snare is deployed in the groove at the tip of the cap. The lesion is then sucked into the cap while the snare is closed. Thus, resection can be safely performed through the submucosal layer under the lesion [45] .
The technique of EMR with ligation (EMR-L; Fig.  4C ) uses a standard endoscopic variceal ligation device to capture the lesion and make it into a polypoid lesion by deploying the band underneath it [46] . The lesion above or below the band is then excised. EMR-C and EMR-L have the advantage of being relatively simple, with the use of a standard endoscope and no requirement for an additional assistant. These techniques how-ever, cannot be used to resect lesions larger than 15 mm in one piece [47, 48] . Specimens obtained following piecemeal resections are diffi cult for the pathologist to analyze, and they render pathological staging inadequate. This is a major factor leading to the high risk of recurrence when these techniques are used (Table 2 ) [49] . In attempt to overcome this problem, a method of en-bloc resection was developed [50] .
Endoscopic techniques that involve direct dissection of the submucosa using modifi ed needle knives have recently been classifi ed as ESD techniques [51] . ESD using an insulation-tipped diathermy knife (IT knife), was fi rst developed at the National Cancer Center Hospital [52, 53] . ESD using the IT knife is perhaps the most commonly performed ESD today in Japan (Fig. 6) [54] . ESD is reputed to be superior to other endoscopic methods in the treatment of EGC, and it provides enbloc specimens with a standard single-channel gastroscope. This novel and promising procedure has the advantage of achieving large en-bloc resections (Fig. 7) ; also, it allows precise histological staging and may prevent disease recurrence. Other devices used for ESD have also been described, such as the hook knife [55] , fl ex knife [56] , and a knife in a small-caliber-tip transparent hood [57] . Despite requiring signifi cant additional technical skills and a longer procedure time [58, 59] , these ESD techniques are rapidly gaining popularity in Japan, primarily because of their ability to remove large EGCs en bloc [60] .
Complications of endoscopic resections
The complications of endoscopic resection for EGC include pain, bleeding, and perforation. Pain after resection is typically mild [61] . Standard doses of proton-pump inhibitors twice a day are prescribed for 8 weeks, and patients are typically fasted for 24 h after the procedure [62] , followed by clear liquid on the second day, and a soft diet on day 3. Bleeding is the most common 
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A Large reddish elevated lesion, 4 cm in size, on the lesser curvature of the middle body; B circumferential mucosal cutting with IT knife with ENDO CUT mode (ERBE, Tubingen, Germany) after administration of diluted epinephrine injection to raise the submucosa; C dissecting the submucosal layer using an IT knife with ENDO CUT mode, after sufficient additional injection of diluted epinephrine injection to prevent perforation complication, occurring in up to 8% of patients undergoing standard EMR and in up to 7% of patients undergoing ESD [63, 64] (Table 3) . Immediate bleeding appears more common with resections of tumors located in the upper third of the stomach. During ESD, im mediate minor bleeding is not uncommon, but it can be successfully treated by grasping and coagulation of the bleeding vessels, using hot biopsy forceps (Fig. 8A,B) (Boston, MA, USA) with 80-W soft-mode coagulation (ICC 200; Erbe, Germany) or bipolar hemostatic forceps (Pentax., Tokyo, Japan) designed to reduce a deeper coagulation effect (30-W bipolar mode with ICC 200 generator) [65] . Endoclips are often deployed for severe bleeding. Delayed bleeding, manifested as hematemesis or melena at 0 to 30 days after the procedure, is treated by emergency endoscopy performed after fl uid resuscitation, using techniques similar to those described [66] . Delayed bleeding is common after ESD and is closely related to tumor location and size [67] .
Perforation is uncommon during EMR, but is seen relatively more commonly during ESD. The risk of perforation during ESD is around 4% (Table 4) . These perforations are typically closed with the aid of endoclips, as previously described (Fig. 8C,D) [68, 69] , because the stomach in patients during gastric EMR or ESD is thought to be comparatively clean due to their fasting before undergoing these procedures, and because of the antibacterial effect of gastric acid.
Vital signs such as blood pressure, oxygen saturation, and electrocardiograms must be checked during endoscopic procedures. If pneumoperitoneum due to perforation (Fig. 8E) is severe, breathing deterioration or neurogenic shock can occur. To prevent these complications (so-called abdominal compartment syndrome), when gastric perforation occurs, decompression of the pneumoperitoneum must be performed with a 14-G puncture needle with side slits under transabdominal ultrasonographic guidance. Recently, in an attempt to minimize the chance of gastric perforation, polyethylene glycol or sodium hyaluronate has been used as the injection agent; this has been reported to help make ESD easier and safer, as these agents stay longer in the submucosa and produce clearer dissection planes [70, 71] . Considering the tissue damage that can occur after injection of the solution during endoscopic resection, an effi cient one should be used [72] .
Pathological assessment after endoscopic resection
Endoscopic resection has generally been unpopular in the West, because of the very low incidence of suitable EGC cases. The diagnostic diffi culties related to endoscopy seem to be a factor, but the low incidence of EGC may also be explained by the different histological criteria applied in the West and Japan; that is to say, most intestinal-type mucosal cancer in Japan is not regarded as a cancer in the West [73] . Whatever the case, such lesions ought to be diagnosed as neoplastic or dysplastic on histology, in line with the Vienna classifi cation [74] , and they should be subjected, where appropriate, to endoscopic resection. The importance of meticulous pathological staging after endoscopic resection cannot be overemphasized. Accurate staging can only be achieved when the specimen is properly oriented by the endoscopist or their assistant immediately after excision in the endoscopy unit prior to the specimen being immersed in formaldehyde.
Orientation of the specimen is best performed by fi xing its periphery with thin needles inserted into an underlying plate of rubber or wood. The submucosal side of the specimen is placed in contact with the plate. After fi xation, the specimen is sectioned serially at 2-mm intervals parallel to a line that includes the closest resection margin of the specimen, so that both lateral and vertical margins are assessed. The depth of tumor invasion (T) is then evaluated, along with the degree of dif- 
Outcomes of endoscopic resection
The outcomes of EMR have been studied in detail. The successful outcomes observed from such studies have allowed EMR to become the standard treatment for EGC in Japan [76] . Kojima and colleagues [77] have reviewed the outcomes of EMR from 12 major institutions in Japan. The inject, lift, and cut, EMR-C, and EMR-L techniques were commonly used and they achieved en-bloc resection in about three-quarters of the patients in whom they were used. The diseasespecifi c survival rate was 99%, although not all studies reported long-term outcomes. As previously mentioned, standard EMR techniques are associated with risks of recurrence, especially when resections are not performed en bloc, or when the resection margins are involved by tumor. The risk of local recurrence after EMR varies from 2% to 35%. ESD is still investigational and demands an extremely high level of skill. In some specialized centers in Japan, the long-term outcomes of patients who have had endoscopic resection using the extended criteria are currently being studied [78] . The incidence of metachronous multiple gastric cancer in patients who have undergone endoscopic resection for the fi rst lesion should be prospectively investigated to determine the interval of suffi cient surveillant endoscopy [79, 80] .
Prospects for the future
Endoscopic procedures for the excision of EGC need to be safe, effective, and applicable to a wide range of clinical situations. One is well aware that the rapid progress of technologies such as ESD has been responsible for advances in the endoscopic resection of EGC. Although several endoscopic devices have been developed solely to make ESD easier and safer, this technique still requires an experienced endoscopist with a high level of skill, because the procedure is performed through only one gastroscope, thus requiring one-handed surgery [81] . Recently, a procedure involving countertraction of lesions for gastric ESD has been described, but it is still under development. In brief, this process involves percutaneous traction-assisted EMR (PTA-EMR) [82] . This invasive procedure is extremely complicated. We prefer a two-handed technique, as in conventional surgery, and are now planning a clinical trial using magnetic-assisted ESD [83] . In order to further extend the indications for treating EGC with less invasive surgery, endoscopic resection combined with laparoscopic regional lymph-node dissection should be considered [84, 85] .
In conclusion, endoscopic resection of EGC is well established as a standard therapy in Japan and is increasingly becoming accepted and regularly used in other countries. The indications, pathological assessment, and techniques of endoscopic resection employed in the treatment of EGC are demanding. ESD, a modifi cation of EMR, has been developed to allow the resection of larger lesions in an en-bloc manner; the early results so far have been really encouraging, although the long-term outcome data are still being monitored. Ideally, continued progress in this fi eld will provide more outcomes research and simplifi ed techniques.
Finally, it is possible that ESD may be used for extended indications in the West. If this occurs, ESD may have a greater therapeutic impact than it does in Japan, because of the higher surgical mortality in the West.
